KU Leuven Secures $2.8 Million Grant to Investigate Origins of Crohn’s Disease Fibrosis

Crohn's disease, affecting approximately 2 million people around the world, manifests with intestinal inflammation and abdominal pain. Current therapies primarily target inflammation using immunosuppressive treatments. However, many patients still endure intestinal fibrosis (the development of scar tissue), necessitating surgery. Researchers from KU Leuven's TARGID Research Centre aim to unravel the underlying fibrosis process to explore potential prevention and treatment avenues. KU Leuven has received a $2.8 million grant from The Leona M. and Harry B. Helmsley Charitable Trust for this endeavor.
account creation

TO READ THIS ARTICLE, CREATE YOUR ACCOUNT

And extend your reading, free of charge and with no commitment.